CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
APAP A (ResMed AirSense AutoSet) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02357706
NCT02357706N/ACompleted
CompareCT.gov

Comparison of Auto-Adjusting Positive Airway Pressure Devices

ResMed·interventional·Posted Feb 6, 2015·Updated Apr 20, 2020

In Brief

A clinical study evaluating APAP A (ResMed AirSense AutoSet) and APAP B (Apex iCH Auto) for Obstructive Sleep Apnea. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Little is understood about how different auto-adjusting PAP devices operate. The purpose of this evaluation is to compare two devices in a randomised two night PSG trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 6, 2015
Enrollment StartJan 1, 2015
Primary CompletionJun 1, 2015
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.4 years ago

Interventions

APAP A (ResMed AirSense AutoSet)device

Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events

APAP B (Apex iCH Auto)device

Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events